Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17029
Country/Region: South Africa
Year: 2016
Main Partner: Witkoppen Health And Welfare Centre
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $1,370,777 Additional Pipeline Funding: $437,759

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $261,707
Care: TB/HIV (HVTB) $180,854
Care: Pediatric Care and Support (PDCS) $71,547
Strategic Information (HVSI) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $80,854
Treatment: Adult Treatment (HTXS) $704,268
Treatment: Pediatric Treatment (PDTX) $71,547
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 1,445
HTS_TST Age/sex: 1-9 2017 1,671
HTS_TST Age/sex: 10-14 Female 2017 89
HTS_TST Age/sex: 10-14 Male 2017 139
HTS_TST Age/sex: 15-19 Female 2017 288
HTS_TST Age/sex: 15-19 Male 2017 451
HTS_TST Age/sex: 20-24 Female 2017 1,015
HTS_TST Age/sex: 20-24 Male 2017 1,589
HTS_TST Age/sex: 25-49 Female 2017 4,059
HTS_TST Age/sex: 25-49 Male 2017 6,353
HTS_TST Age/sex: 50+ Female 2017 828
HTS_TST Age/sex: 50+ Male 2017 1,297
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 3,204
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 139
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 6,190
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 9,691
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 19,224
HTS_TST Service Delivery Point (Community): Homebased testing 2017 230
HTS_TST Service Delivery Point (Community): Index testing 2017 250
HTS_TST Service Delivery Point (Community): Mobile testing 2017 3,845
HTS_TST Service Delivery Point (Community): Other 2017 481
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,971
HTS_TST Service Delivery Point (Facility): Pediatric 2017 2,507
HTS_TST Service Delivery Point (Facility): PMTCT 2017 3,325
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 615
HTS_TST Sum of Age/Sex disaggregates 2017 16,108
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,343
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 15,881
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 19,224
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 20
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 11
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 66
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 36
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 231
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 124
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 926
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 494
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 189
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 101
HTS_TST_POS Test Result by Age: Positive: <1 2017 197
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 188
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 199
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 199
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,431
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 754
PMTCT_ART Already on ART at beginning of current pregnancy 2017 252
PMTCT_ART New on ART 2017 606
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 3,175
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 876
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 22
PMTCT_EID Sum of Infant Age disaggregates 2017 876
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 238
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 897
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 2,040
PMTCT_STAT By: Known positives at entry 2017 934
PMTCT_STAT By: Number of new positives identified 2017 2,241
PMTCT_STAT Number of new ANC and L&D clients 2017 3,325
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 3,175
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 70
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 264
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 600
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 168
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 633
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 1,440
PMTCT_STAT Sum of Positives Status disaggregates 2017 3,175
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 249
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 939
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 2,137
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 13
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 428
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 122
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 567
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 317
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 554
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 554
TB_SCREENDX Screen Result: Screened Positive for TB 2017 615
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 11,621
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 3,291
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 365
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 103
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 15,380
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 13
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 544
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 8
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 319
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 494
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 884
TX_CURR Age/Sex: <1 2017 60
TX_CURR Age/Sex: <1-9 2017 133
TX_CURR Age/Sex: 10-14 Female 2017 32
TX_CURR Age/Sex: 10-14 Male 2017 28
TX_CURR Age/Sex: 15-19 Female 2017 83
TX_CURR Age/Sex: 15-19 Male 2017 18
TX_CURR Age/Sex: 20-24 Female 2017 560
TX_CURR Age/Sex: 20-24 Male 2017 55
TX_CURR Age/Sex: 25-49 Female 2017 4,092
TX_CURR Age/Sex: 25-49 Male 2017 2,663
TX_CURR Age/Sex: 50+ Female 2017 353
TX_CURR Age/Sex: 50+ Male 2017 220
TX_CURR Aggregated Age/Sex: <15 Female 2017 255
TX_CURR Aggregated Age/Sex: <15 Male 2017 214
TX_CURR Aggregated Age/Sex: 15+ Female 2017 4,988
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,840
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 8,297
TX_CURR Sum of age/sex disaggregates 2017 101
TX_CURR Sum of Aggregated Age/Sex <15 2017 469
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 7,828
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 8,297
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 38
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 29
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,357
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 788
TX_NEW By Age/Sex: <1 2017 16
TX_NEW By Age/Sex: 1-9 2017 35
TX_NEW By Age/Sex: 10-14 Female 2017 9
TX_NEW By Age/Sex: 10-14 Male 2017 7
TX_NEW By Age/Sex: 15-19 Female 2017 22
TX_NEW By Age/Sex: 15-19 Male 2017 5
TX_NEW By Age/Sex: 20-24 Female 2017 149
TX_NEW By Age/Sex: 20-24 Male 2017 15
TX_NEW By Age/Sex: 25-49 Female 2017 1,091
TX_NEW By Age/Sex: 25-49 Male 2017 710
TX_NEW By Age/Sex: 50+ Female 2017 94
TX_NEW By Age/Sex: 50+ Male 2017 59
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,212
TX_NEW Sum of Age/Sex disaggregates 2017 2,161
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,212
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 7,468
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 6,721
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 207
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 174
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 4,039
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,301
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 230
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 193
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 4,489
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 2,556
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 29
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 64
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 16
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 40
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 270
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 27
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,976
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,285
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 171
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 106
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 123
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 103
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,409
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,371
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 4,006
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 4,262
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 31
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 68
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 16
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 14
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 42
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 288
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 28
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,104
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,368
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 181
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 113
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 131
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 110
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,562
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,459